title: Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
abstract: Osteoporosis is a condition marked by low bone mineral density and the deterioration of bone tissue. One of the main clinical and economic consequences of osteoporosis is skeletal fractures. To assess the healthcare and work loss costs of US patients with non-vertebral (NV) osteoporotic fractures. Privately insured (aged 18-64 years) and Medicare (aged >/=65 years) patients with osteoporosis (ICD-9-CM code: 733.0x) were identified during 1999-2006 using two claims databases. Patients with an NV fracture (femur, pelvis, lower leg, upper arm, forearm, rib or hip) were matched randomly on age, sex, employment status and geographic region to controls with osteoporosis and no fractures. Patient characteristics and annual healthcare costs were assessed over the year following the index fracture for privately insured (n = 4764) and Medicare (n = 48 742) beneficiaries (Medicare drug costs were estimated using multivariable models). Indirect (i.e. work loss) costs were calculated for a subset of privately insured, employed patients with available disability data (n = 1148). All costs were reported in $US, year 2006 values. In Medicare, mean incremental healthcare costs per NV fracture patient were $US13 387 ($US22 466 vs $US9079; p < 0.05). The most expensive patients had index fractures of the hip, multiple sites and femur (incremental costs of $US25 519, $US20 137 and $US19 403, respectively). Patients with NV non-hip (NVNH) fractures had incremental healthcare costs of $US7868 per patient ($US16 704 vs $US8836; p < 0.05). Aggregate annual incremental healthcare costs of NVNH patients in the Medicare research sample (n = 35 933) were $US282.7 million compared with $US204.1 million for hip fracture patients (n = 7997). Among the privately insured, mean incremental healthcare costs per NV fracture patient were $US5961 ($US11 636 vs $US5675; p < 0.05). The most expensive patients had index fractures of the hip, multiple sites and pelvis (incremental costs of $US13 801, $US9642 and $US8164, respectively). Annual incremental healthcare costs per NVNH patient were $US5381 ($US11 090 vs $US5709; p < 0.05). Aggregate annual incremental healthcare costs of NVNH patients in the privately insured sample (n = 4478) were $US24.1 million compared with $US3.5 million for hip fracture patients (n = 255). Mean incremental work loss costs per NV fracture employee were $US1956 ($US4349 vs $US2393; p < 0.05). Among patients with available disability data, work loss accounted for 29.5% of total costs per NV fracture employee. The cost burden of NV fracture patients to payers is substantial. Although hip fracture patients were more costly per patient in both Medicare and privately insured samples, NVNH fracture patients still had substantial incremental costs. Because NVNH patients accounted for a larger proportion of the fracture population, they were associated with greater aggregate incremental healthcare costs than hip fracture patients.
authors.affiliation: Analysis Group, Inc., Boston, Massachusetts, USA.
authors.forename: Crystal
authors.initials: C
authors.lastname: Pike
authors.forename: Howard G
authors.initials: HG
authors.lastname: Birnbaum
authors.forename: Matt
authors.initials: M
authors.lastname: Schiller
authors.forename: Hari
authors.initials: H
authors.lastname: Sharma
authors.forename: Russel
authors.initials: R
authors.lastname: Burge
authors.forename: Eric T
authors.initials: ET
authors.lastname: Edgell
mesh_terms: D000041:Absenteeism; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000553:Ambulatory Care / Q000191:economics / Q000706:statistics & numerical data; D015897:Comorbidity; D017281:Cost of Illness; D016527:Drug Costs / Q000706:statistics & numerical data; D004632:Emergency Medical Services / Q000191:economics / Q000706:statistics & numerical data; D005260:Female; D050723:Fractures, Bone / Q000175:diagnosis / Q000191:economics* / Q000209:etiology* / Q000628:therapy; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000191:economics / Q000706:statistics & numerical data; D006801:Humans; D007297:Inpatients / Q000706:statistics & numerical data; D007342:Insurance Benefits / Q000706:statistics & numerical data; D018868:Insurance, Disability; D007348:Insurance, Health / Q000706:statistics & numerical data; D008134:Long-Term Care / Q000191:economics / Q000706:statistics & numerical data; D008297:Male; D006278:Medicare / Q000706:statistics & numerical data; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications* / Q000191:economics / Q000628:therapy; D012737:Sex Factors; D018582:Sick Leave / Q000706:statistics & numerical data; D014481:United States
references.citation: Osteoporos Int. 2009 Apr;20(4):527-36
references.pmid: 18766294
references.citation: Bone. 2002 Apr;30(4):631-6
references.pmid: 11934657
references.citation: Osteoporos Int. 2005 Jan;16(1):78-85
references.pmid: 15167988
references.citation: J Chronic Dis. 1987;40(5):373-83
references.pmid: 3558716
references.citation: Osteoporos Int. 2003 Jun;14(5):383-8
references.pmid: 12730750
references.citation: Rheumatol Int. 2006 Oct;26(12):1063-72
references.pmid: 16953395
references.citation: Osteoporos Int. 2006 Feb;17(2):252-8
references.pmid: 16193229
references.citation: Dis Manag. 2003 Summer;6(2):83-91
references.pmid: 14577902
references.citation: J Bone Miner Res. 2003 Jun;18(6):1139-41
references.pmid: 12817771
references.citation: Pharmacoeconomics. 2006;24(9):869-90
references.pmid: 16942122
references.citation: Bone. 1994 Jul-Aug;15(4):377-86
references.pmid: 7917575
references.citation: Womens Health Issues. 2005 May-Jun;15(3):97-108
references.pmid: 15894195
references.citation: Osteoporos Int. 2005 Apr;16(4):359-71
references.pmid: 15340799
references.citation: Curr Med Res Opin. 2008 Jun;24(6):1781-8
references.pmid: 18489813
references.citation: Foot Ankle Int. 1998 Apr;19(4):221-4
references.pmid: 9578100
references.citation: Osteoporos Int. 2005 Dec;16(12):2046-52
references.pmid: 16228106
references.citation: Value Health. 2007 Mar-Apr;10(2):144-52
references.pmid: 17391423
references.citation: Methods Mol Biol. 2008;455:125-34
references.pmid: 18463815
references.citation: JAMA. 2001 Dec 12;286(22):2815-22
references.pmid: 11735756
references.citation: Osteoporos Int. 2001 Dec;12(12):1042-9
references.pmid: 11846331
references.citation: J Bone Miner Res. 1997 Jan;12(1):24-35
references.pmid: 9240722
references.citation: Gerontology. 2001 Jan-Feb;47(1):21-9
references.pmid: 11244288
references.citation: J Clin Epidemiol. 1993 Oct;46(10):1075-9; discussion 1081-90
references.pmid: 8410092
references.citation: Clin Orthop Relat Res. 1980 Jul-Aug;(150):172-6
references.pmid: 7428216
references.citation: Clin Geriatr Med. 2002 Aug;18(3):529-55
references.pmid: 12424871
references.citation: Osteoporos Int. 2005 Dec;16(12):1545-57
references.pmid: 15942702
references.citation: J Bone Joint Surg Am. 2003 May;85(5):820-4
references.pmid: 12728031
references.citation: Curr Med Res Opin. 2008 Mar;24(3):695-705
references.pmid: 18226324
references.citation: J Bone Miner Res. 2007 Mar;22(3):465-75
references.pmid: 17144789